Significance of diffusing capacity of the lungs for carbon monoxide on chronic thromboembolic pulmonary hypertension

Reduced diffusing capacity of the lungs for carbon monoxide (DLco) reflects microvasculopathy in chronic thromboembolic pulmonary hypertension, yet its clinical value is uncertain. In a Japanese nationwide registry (2018-2023) we studied 1270 patients: 486 formed an event cohort and 299 a treatment cohort who underwent pulmonary endarterectomy or balloon pulmonary angioplasty. Lower baseline DLco was indicative of smaller postprocedural improvements in mean pulmonary artery pressure, pulmonary vascular resistance and cardiac index (all p≤0.023) and a higher risk of clinical events (HR 0.971, p=0.005). Outcomes deteriorated below 59.6%, indicating DLco may help stratify prognosis and treatment benefit.

Authors

Institutions

Publication Details

Journal
Thorax
Published
2026-01-07
DOI
https://doi.org/10.1136/thorax-2025-223670
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Significance of diffusing capacity of the lungs for carbon monoxide on chronic thromboembolic pulmonary hypertension

Ayako Shigeta, Hidekazu Ikemiyagi, Kouta Funakoshi, Kayoko Kubota et al.
Thorax
Pulmonary Hypertension Research and Treatments
article

Significance of diffusing capacity of the lungs for carbon monoxide on chronic thromboembolic pulmonary hypertension

Ayako Shigeta, Hidekazu Ikemiyagi, Kouta Funakoshi, Kayoko Kubota, Koshin Horimoto, Ichizo Tsujino, Shiro Adachi, Yoshihiro Dohi, Y. Fukumoto, Nobutaka Ikeda, Takashi Kawakami, Nobuhiro Tanabe, Koichiro Tatsumi, Nobuhiro Yaoita, Yoshito Ogihara, Yuichi Tamura, Takahiro Hiraide, Takumi Inami, Shun Minatsuki, Hitoshi Ogino, Masaru Hatano, Hiroto Shimokawahara, Jun Yamashita, Yu Taniguchi, Kazuya Hosokawa, Kohtaro Abe
article en

Abstract

Reduced diffusing capacity of the lungs for carbon monoxide (DLco) reflects microvasculopathy in chronic thromboembolic pulmonary hypertension, yet its clinical value is uncertain. In a Japanese nationwide registry (2018-2023) we studied 1270 patients: 486 formed an event cohort and 299 a treatment cohort who underwent pulmonary endarterectomy or balloon pulmonary angioplasty. Lower baseline DLco was indicative of smaller postprocedural improvements in mean pulmonary artery pressure, pulmonary vascular resistance and cardiac index (all p≤0.023) and a higher risk of clinical events (HR 0.971, p=0.005). Outcomes deteriorated below 59.6%, indicating DLco may help stratify prognosis and treatment benefit.

Thorax
Kurume University (JP), Kagoshima University (JP), SHOWA Medical University (JP), Toho University (JP), Kyushu University (JP), Tokyo Medical University (JP), Chiba University (JP), Mie University (JP), Kyorin University (JP), Keio University (JP), Hokkaido University (JP), University of the Ryukyus (JP), Chibaken Saiseikai Narashino Hospital (JP), Toho University Ohashi Medical Center (JP), Tohoku University Hospital (JP), Kyushu University Hospital (JP), Matsuyama Red Cross Hospital (JP), Kure Kyosai Hospital (JP), National Hospital Organization (JP), Okayama Medical Center (JP), Mita Hospital (JP), Nagoya University (JP), Kobe University (JP), The University of Tokyo (JP)
Openalex Percentile: Top 96%
Pulmonary Hypertension Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.